ElAshmawy Wagdy R, Okello Emmanuel, Williams Deniece R, Anderson Randall J, Karle Betsy, Lehenbauer Terry W, Aly Sharif S
Veterinary Medicine Teaching and Research Center, School of Veterinary Medicine, University of California Davis, Tulare, CA 93274, USA.
Department of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza 12613, Egypt.
Vet Sci. 2022 Oct 11;9(10):559. doi: 10.3390/vetsci9100559.
Mastitis is the greatest disease challenge for dairy producers, with substantial economic impacts due to lost milk production. Amongst the approaches implemented to control and prevent mastitis on dairies are vaccination, pre- and post-milking teat dips, and treatments at dry-off including intramammary antibiotics and teat sealants. The objectives of our study were to evaluate the effect of different treatments at dry-off on the subsequent lactation's milk production and somatic cell count (SCC). A single-blinded controlled block randomized clinical trial was conducted between December 2016 and August 2018 on eight herds from four of the top ten milk-producing counties in California: Tulare, Kings, Stanislaus, and San Joaquin. The trial was repeated with cows enrolled during the winter and summer seasons to account for seasonal variability. Eligible cows were treated at dry-off with either intramammary antibiotics (AB), internal teat sealant (TS), AB + TS, or did not receive any treatment (control), and were followed through 150 days in milk (DIM) post-calving. The milk production and SCC data were extracted from monthly test day milk records (Dairy Comp 305, Valley Ag Software, Tulare, CA, USA). Two-piece spline linear mixed models were used to model the milk production (kg) and natural logarithm-transformed SCC. After accounting for parity, breed, season, and dry period duration, the milk model showed a significant increase in milk production (1.84 kg/day) in cows treated with AB + TS at dry-off in comparison to controls. There was no significant difference in the milk produced by cows that received either AB or TS (0.12 kg/day, and 0.67 kg/day, respectively) in comparison to the untreated cows. Different dry cow treatments were associated with a significant reduction in ln SCC during the first 150 DIM. The greatest reduction was associated with using AB + TS, followed by AB, and finally TS in comparison to controls. Dairies with high SCC may benefit from treating cows at dry-off with AB, TS, or both.
乳腺炎是奶业生产者面临的最大疾病挑战,因产奶量损失而造成巨大经济影响。在奶场实施的控制和预防乳腺炎的方法中,包括接种疫苗、挤奶前后的乳头药浴,以及干奶期处理,如乳房内注射抗生素和乳头封闭剂。我们研究的目的是评估干奶期不同处理对随后泌乳期产奶量和体细胞计数(SCC)的影响。2016年12月至2018年8月,在加利福尼亚州十大产奶县中的四个县(图莱里、金斯、斯坦尼斯劳斯和圣华金)的八个牛群中进行了一项单盲对照区组随机临床试验。该试验在冬季和夏季入组的奶牛中重复进行,以考虑季节变异性。符合条件的奶牛在干奶期接受乳房内抗生素(AB)、内部乳头封闭剂(TS)、AB + TS处理,或不接受任何处理(对照),并在产犊后150天的泌乳天数(DIM)内进行跟踪。产奶量和SCC数据从每月的测定日牛奶记录(Dairy Comp 305,Valley Ag Software,美国加利福尼亚州图莱里)中提取。使用两段样条线性混合模型对产奶量(千克)和自然对数转换后的SCC进行建模。在考虑胎次、品种、季节和干奶期持续时间后,产奶量模型显示,与对照组相比,干奶期接受AB + TS处理的奶牛产奶量显著增加(1.84千克/天)。与未处理的奶牛相比,接受AB或TS处理的奶牛产奶量没有显著差异(分别为0.12千克/天和0.67千克/天)。不同的干奶牛处理与泌乳期前150天ln SCC的显著降低有关。与对照组相比,最大降幅与使用AB + TS有关,其次是AB,最后是TS。SCC高的奶场可能会从干奶期用AB、TS或两者同时处理奶牛中受益。